By Deena Beasley (Reuters) - Mirati Therapeutics Inc's experimental drug that targets a specific genetic mutation helped about one third of a small su.
Mirati Therapeutics Inc s experimental drug that targets a specific genetic mutation helped about one third of a small subset of patients in a clinica.
Mirati Therapeutics Inc s experimental drug that targets a specific genetic mutation helped about one third of a small subset of patients in a clinica.